Metformin 'holds promise' for treating preterm pre-eclampsia: study
The diabetes drug could be repurposed to prolong gestation in select pregnant women, researchers say
Metformin could prolong gestation by a week and improve fetal and maternal outcomes in women with preterm pre-eclampsia, an Australian and South African study suggests.
The randomised, double-blind trial provides proof of concept that treatment for the hypertensive disorder of pregnancy is possible, the researchers say.
"It is the first time that a treatment given to [women] with preterm pre-eclampsia to keep them pregnant for a week longer might have worked,” said first author
